Ursula von der Leyen, European Commission president.
Bloomberg | Bloomberg | Getty Images
LONDON — European Commission President Ursula von der Leyen said it herself: “The start was tough.”
The European Union has had a bumpy Covid-19 vaccine rollout. The campaign has prompted complaints that regulators were too slow to approve the shots and led to a simmering tussle with AstraZeneca as the pharmaceutical giant repeatedly slashed its delivery commitments.
More recently, several countries briefly halted their use of the Oxford-AstraZeneca vaccine amid safety concerns, a move that baffled health experts and raised questions about future uptake.
The World Health Organization expressed concern…
Source cnbc.com